Despite decades of conflicting studies about the pungent herb's ability to improve heart health, the researchers say their study provides the most rigorous evidence to date that consuming garlic on a daily basis - in the form of either raw garlic or two of the most popular garlic supplements - does not lower LDL cholesterol levels among adults with moderately high cholesterol levels.
"It just doesn't work," said senior author Christopher Gardner, PhD, assistant professor of medicine at the Stanford Prevention Research Center. "There's no shortcut. You achieve good health through eating healthy food. There isn't a pill or an herb you can take to counteract an unhealthy diet."
Gardner said the study, which will be published in the Feb. 26 issue of the Archives of Internal Medicine, is the first independent, long-term, head-to-head assessment of raw garlic and garlic supplements. The study also drew on the expertise of two of the nation's foremost garlic experts - Larry Lawson, PhD, of the Plant Bioactives Research Institute in Utah, and Eric Block, PhD, professor of chemistry at the University at Albany, State University of New York - who have devoted much of their careers to understanding the biochemical properties of the herb and who ensured the quality and stability of the garlic consumed in the study.
"If garlic was going to work, in one form or another, then it would have worked in our study," Gardner said. "The lack of effect was compelling and clear. We took cholesterol measurements every month for six months and the numbers just didn't move. There was no effect with any of the three products, even though fairly high doses were used."
Most of the medicinal claims about garlic revolve around the sulfur-containing substance allicin, which is produced when raw garlic is chopped or crushed. Allicin has been shown to inhibit the synthesis of cholesterol in test tubes and in animal models, but there is conflicting clinical evidence about its ability to react inside the human body the same way it does in a lab dish.
"In lab tests, you can apply the garlic compounds directly to cells," Gardner said. "But in real people you don't know whether allicin would actually get directly to cells if someone ate garlic. You still have to do the human clinical trial to see if it really works, and the previous clinical trials left people confused."
Indeed, the fact that allicin had positive results in some lab tests and animal studies made it possible for supplement makers to tout garlic as a natural remedy for high LDL cholesterol levels. LDL cholesterol is known as the "bad cholesterol" because when too much of the substance circulates in the blood, it can build up and clog arteries, increasing the risk of heart attack or stroke. LDL levels of less than 130 mg/dl are considered optimal, while levels greater than that are considered high.
For the study, the researchers recruited 192 patients with moderately elevated LDL cholesterol levels, with an average level of about 140 mg/dl. "These are the people who are the most likely to use supplements," Gardner said. "If their cholesterol were higher, then their doctors would be putting them on statins or some other prescription medication."
The study participants were then randomly assigned to ingest either raw garlic, an aged garlic supplement, a powdered garlic supplement or a placebo six days a week for six months. For those assigned to take either raw or supplemental forms of garlic, each participant consumed the equivalent of a 4-gram clove of garlic per day (which the researchers determined was the average size of a clove of garlic). For those assigned to the supplements, this meant taking somewhat more than the dosage recommended on the packaging instructions for both supplements.
The garlic supplements used in the study are two of the top sellers, but are manufactured in very different ways. Gardner said that the manufacturer of the aged garlic extract calls it "the 'sociable' garlic because they say the aging process takes away the bad-breath aspect." Extensive chemical analyses of the three garlic products confirmed that the daily doses represented similar amounts of the original starting material and that all three remained stable over the course of the study.
All of the study participants were given tablets as well as sandwiches prepared by Gardner's team. For those assigned to consume raw garlic, the garlic was mixed into the sandwich condiments, and the pills were placebos. For those assigned to take supplements, the condiments were garlic-free. In all, the research team made more than 30,000 heart-healthy gourmet sandwiches for the six-month study.
Participants were closely monitored throughout the study to ensure that they didn't gain or lose weight, which might have affected their cholesterol readings. Additionally, blood samples were taken monthly from the study participants.
When the researchers tested the blood samples, they found that the LDL cholesterol readings remained nearly identical from start to finish.
"Our study had the statistical power to see any small differences that would have shown up, and we had the duration to see whether it might take a while for the effect of the garlic to creep in. We even looked separately at the participants with the highest vs. the lowest LDL cholesterol levels at the start of the study, and the results were identical," Gardner said. "Garlic just didn't work."
One potential reason for the confusion surrounding garlic's reputed health benefits is that the supplement makers themselves funded many of the previous studies claiming that garlic lowered cholesterol. Gardner's funding came from the National Institutes of Health.
Gardner said garlic may still have an effect on other health and disease processes that were not addressed in this study, such as inflammation, immune function or cancer. But, he added, those potential benefits also need to be studied in rigorously controlled trials.
He also said that garlic can still be a valuable part of the diet if it's used to increase the consumption of healthy dishes, such as a stir fry or a Mediterranean salad. "But if you choose garlic fries as a cholesterol-lowering food, then you blew it. The garlic doesn't counteract the fries," Gardner said.
Susan Ipaktchian | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering